01Medicine developmentWhat it doesLionBio Therapeutics is led by a founder who helped start a16z’s early-stage program Speedrun four years ago and left a year ago to build a company of his own.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
03Why it mattersLionBio's $6M Pre-Seed round adds capital to the Unclassified category, where the deal ranks at the 26th percentile of tracked rounds by size.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
